CA
NZ
UK
AU
IND
US
Accenture's guidance reduction was initially treated as an earnings disappointment. Slower expected revenue growth and pressure in parts of the government business gave investors clear reasons to reassess near-term forecasts.
Arena REIT (ASX:ARF) shares traded higher during the morning session on 19 June 2026 after the property group released a market update outlining portfolio valuation gains, development activity, portfolio transactions and distributions for FY26. The stock rose 2.69% to AUD 3.24, gaining AUD 0.085 …
Space Exploration Technologies (NASDAQ:SPCX) declined sharply on Thursday as momentum from its record-breaking initial public offering began to fade. Shares fell roughly 9%, extending losses after a 5% decline in the previous session and marking the stock's steepest pullback since listing.
Nvidia is extending its influence beyond artificial intelligence chips and emerging as a major force in the networking infrastructure that powers AI data centers.
Marvell Technology (NASDAQ:MRVL) shares surged on June 18, with the stock climbing 13.7% to $329.30, a gain of $39.76 for the session, as investors responded positively to a series of announcements reinforcing the company’s position in the rapidly expanding artificial intelligence infrastructure market.
U.S. gasoline prices fell below $4 per gallon on Thursday for the first time in nearly three months as traders responded to expectations that oil exports through the Strait of Hormuz will gradually recover following the U.S.-Iran peace agreement.
The Federal Energy Regulatory Commission has launched a broad review of how large electricity consumers connect to the U.S. power grid, responding to rapidly rising demand from data centers and artificial intelligence infrastructure.
Moderna Inc. (NASDAQ: MRNA) is awaiting a pivotal recommendation from a federal vaccine advisory committee as regulators evaluate the safety and effectiveness of its experimental influenza vaccine for adults aged 50 and older. The review is being closely watched across the biotechnology sector because …
Kardigan made a strong debut on the public markets after the cardiovascular drug developer completed a $400 million upsized initial public offering, reflecting improving investor sentiment toward biotechnology listings.
New Fortress Energy Inc. (NASDAQ: NFE) has received approval from the High Court of Justice of England and Wales for its proposed UK restructuring plan, advancing a key component of the company's efforts to address its debt obligations and improve financial flexibility.
Please wait processing your request...